January 2018

Letter from the Editor

January 1, 2018

Tired of “innovation“ yet? No doubt that innovation is one of those “buzz-tion” words — transformation, collaboration, disruption — that some might deride as having been used so frequently that it has lost some of its inherent value as an action-based, momentum-driving movement. I say nay. Innovation is the life-blood of our industry, or at […]

Upfront

January 1, 2018

Merck Expands Donation Program Merck has expanded the Mectizan Donation Program (MDP) to reach an additional 100 million people a year through 2025 as part of its global effort to eliminate lymphatic filariasis (LF). Through the MDP, established by Merck in 1987, the company donates Mectizan for onchocerciasis (river blindness) in Latin America, Africa, Yemen […]

Innovator’s Corner

January 1, 2018

Next-Generation Immuno-Oncology Stephen Isaacs, President and CEO of Aduro Biotech, talks about the company’s research of a small molecule that acts as a personalized “vaccine” against cancer. In recent years, we have seen the development and approval of immuno-oncology therapies that increase the strength of immune responses against tumors. These therapies have been a tremendous […]

HealthTech

January 1, 2018

Apple Watch Expands Capabilities to improve health outcomes in cardiac, diabetes, depression Trend Watch: Apple Watch continues to revolutionize health data collection. Did you get an Apple Watch for the holidays? Lucky you, especially since several additional capabilities were unveiled at the end of last year, just in time for the gift giving season. For […]

Last Word

January 1, 2018

Supporting Caregivers Scott Williams, VP, Head of Global Patient Advocacy and Strategic Partnerships, EMD Serono, talks about the company’s efforts to recognize and support unpaid caregivers. PV: What is the Embracing Carers program and EMD Serono’s role? Williams: Embracing Carers is a global movement to shine a light on the contributions that carers make to […]

Pharma Innovation Labs

January 1, 2018

Innovative or collaborative partnerships in pharma are being touted by some as the “new normal.” Certainly, this is true of several pioneering pharmaceutical companies in the space, but authentic, independent or open-source collaborations are still a minority in the life-sciences ecosystem. The bright spot is that there are several companies that have created in-house innovation […]

Disruptive Advertising

January 1, 2018

Technology disruptions in our world are becoming routine, and consumers are becoming impervious to the daily assault on their attention. In order to be effective, brand marketers need to rise above and beyond an ever-rising bar of campaign creativity, as well as use technology to break through all the noise that distracts their audiences. This […]

Next-Generation Nanomedicines

January 1, 2018

The first generation of nanotechnology-based medicines, including nano-based drug delivery systems and nanovectors, improved the safe delivery of therapies that were once toxic. Nanoparticles have also proven to be especially good vehicles to effectively deliver cancer drugs, where many therapies are toxic in high doses, because they can minimize or negate potential off-target effects. Nano-delivery […]

Pricing Front and Center

January 1, 2018

Pharmaceutical pricing is a complex — and often controversial — issue impacting all stakeholders in healthcare. Discussions around value, fair pricing, transparency, outcomes, and patient affordability are front and center as companies try to provide some insight, but each stakeholder in this group of cohorts has very different needs. There is no easy way to […]

SHOWCASE FEATURE: Social Media: Taking the Plunge: Pharma and Social Media

January 1, 2018

Pharmaceutical companies are increasingly embracing social media as a forum for reaching patients. For example, 40% of adults use social media for health-related issues, such as connecting with patients with similar issues. Social forums allow pharmaceutical companies to not only engage with consumers or patients, but also hear what they have to say directly, rather […]

“I Want My Brand on Social!”

January 1, 2018

Social media is ubiquitous. Everyone is on it in some capacity. We are all hands-on experts; but social is very nuanced. How do I leverage creative, messaging, audience, device, time of day, etc., to connect with my customers? A successful start requires focus on a strategy—one that is as individual as the person you are […]

Transcending Traditional Social Media: From Awareness to Uncovering Actionable Insights

January 1, 2018

It goes without saying that social media is one of the most widely used forms of communication today. Pharmaceutical companies are trying to “crack the code” and understand how to effectively use this channel to achieve organizational initiatives while complying with rigorous industry regulations. Progressive companies have navigated this challenging environment, breaking new ground and […]

Industry Gears Up For Track and Trace

January 1, 2018

Counterfeit medicines have taken a huge toll, both in terms of human costs as well as financially. Interpol estimates that 1 million deaths each year can be linked to counterfeits. According to PwC, counterfeit pharmaceuticals are a $200 billion-plus annual business. The problem is most severe in lower income countries with between 10% and 30% […]

Women’s Healthcare: Drug Development

January 1, 2018

With a U.S. healthcare market estimated at $2.8 trillion and purchasing either made or largely influenced by women, the “power of the purse” has never been stronger. According to Carolyn Buck Luce, executive-in-residence at the Center for Talent Innovation and an adjunct professor at Columbia University who teaches Women and Power, and co-founder of Imaginal […]

Red Zone: Applying User Experience Design to Develop Effective Patient Suport

January 1, 2018

Treatment nonadherence is a complex behavior that requires much more than a simple one-size-fits-all approach to address the challenge. What can pharma learn from the behavioral sciences to deliver patient support that is effective in improving tx adherence? Health psychology and behavioral economics provide us with theories and insights to develop effective patient support programs […]

FEEDBACK